APONVIE Trademark

Trademark Overview


On Tuesday, September 21, 2021, a trademark application was filed for APONVIE with the United States Patent and Trademark Office. The USPTO has given the APONVIE trademark a serial number of 97038308. The federal status of this trademark filing is REGISTERED as of Tuesday, May 2, 2023. This trademark is owned by Heron Therapeutics, Inc.. The APONVIE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
aponvie

General Information


Serial Number97038308
Word MarkAPONVIE
Filing DateTuesday, September 21, 2021
Status700 - REGISTERED
Status DateTuesday, May 2, 2023
Registration Number7044489
Registration DateTuesday, May 2, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2022

Trademark Statements


Goods and ServicesAnti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 25, 2021
Primary Code005
First Use Anywhere DateThursday, March 2, 2023
First Use In Commerce DateThursday, March 2, 2023

Trademark Owner History


Party NameHeron Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameHeron Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameHeron Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Wednesday, August 16, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 2, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 2, 2023REGISTERED-PRINCIPAL REGISTER
Friday, March 31, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, March 30, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 24, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 8, 2023USE AMENDMENT FILED
Friday, March 24, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 8, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Tuesday, January 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, December 4, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, August 11, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 23, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 23, 2022ASSIGNED TO EXAMINER
Monday, October 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 24, 2021NEW APPLICATION ENTERED